Seeking Alpha

KERX
Keryx Biopharmaceuticals, Inc. - NASDAQ

4/16/2014, 9:04 AM ET
Quote & Analysis Breaking News StockTalk
kerx chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
KERX vs. ETF Alternatives
Company Description

Keryx Biopharmaceuticals, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It is developing ZerenexTM an oral, ferric iron-based compound.